businesspress24.com - Cromos Pharma Opens an Office in the Republic of Georgia
 

Cromos Pharma Opens an Office in the Republic of Georgia

ID: 1216626

(firmenpresse) - MOSCOW -- (Marketwired) -- 04/16/13 -- Cromos Pharma, an international full service contract research organization (CRO), announced today that it opened an office in the Republic of Georgia.

"Georgia is a very important location for Cromos Pharma," noted Dr. Vladimir Bogin, Chief Executive Officer of Cromos Pharma. "Some of the unique qualities of Georgia are its very streamlined and time-efficient regulatory approval process, good quality of medical care and historically high recruitment and retention rates."

"We were very lucky to have been able to attract a very experienced professional team to our new office in Tbilisi. Its unique expertise and established relationships with key opinion leaders and investigators guarantees that Cromos Pharma will provide both high rate of recruitment and competitive, quality services in yet another country," said Andrey Tarakanov, MD, Cromos Pharma's Managing Director.

With addition of Georgia, Cromos Pharma plans to compete for an even larger number of multi-center, international clinical trials. Employing its cloud-based software system, the company has been able to achieve a seamless integration of the Tbilisi office, which is now part of Cromos Pharma's successful and cost-efficient virtual workplace model.

About Cromos Pharma, LLC
Cromos Pharma, LLC is a contract research organization (CRO) with operations in Russia, Ukraine and Eastern Europe and a business development office in the United States. The company provides a full spectrum of trial-related services which include regulatory approvals, medical writing, feasibility assessments, monitoring, project management and warehousing. Cromos Pharma, LLC is a privately owned company.





Contact information for Russia, Ukraine and countries of C&E Europe:
Vladimir Krechikov, MD, PhD
Director of Business Development
Tel: +7 495 748 02 37
Toll free (for calls within Russia only): 8 800 100 21 78




Fax: +7 495 748 02 38
Email:


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Sarepta Therapeutics Announces FDA Will Consider Accelerated Approval for Eteplirsen After Further Review of Data on Dystrophin and Clinical Outcomes
Cytovance(R) Biologics to Expand Microbial Manufacturing
Bereitgestellt von Benutzer: Marketwired
Datum: 16.04.2013 - 01:05 Uhr
Sprache: Deutsch
News-ID 1216626
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

MOSCOW


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 279 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Cromos Pharma Opens an Office in the Republic of Georgia
"
steht unter der journalistisch-redaktionellen Verantwortung von

Cromos Pharma (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Cromos Pharma



 

Who is online

All members: 10 566
Register today: 1
Register yesterday: 0
Members online: 0
Guests online: 101


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.